These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12450694)

  • 1. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.
    Sougioultzis S; Lee CK; Alsahli M; Banerjee S; Cadoz M; Schrader R; Guy B; Bedford P; Monath TP; Kelly CP; Michetti P
    Vaccine; 2002 Dec; 21(3-4):194-201. PubMed ID: 12450694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.
    Banerjee S; Medina-Fatimi A; Nichols R; Tendler D; Michetti M; Simon J; Kelly CP; Monath TP; Michetti P
    Gut; 2002 Nov; 51(5):634-40. PubMed ID: 12377799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
    Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
    Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
    Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against Helicobacter pylori in non-human primate models and humans.
    Lee CK
    Scand J Immunol; 2001 May; 53(5):437-42. PubMed ID: 11309150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
    Kleanthous H; Myers GA; Georgakopoulos KM; Tibbitts TJ; Ingrassia JW; Gray HL; Ding R; Zhang ZZ; Lei W; Nichols R; Lee CK; Ermak TH; Monath TP
    Infect Immun; 1998 Jun; 66(6):2879-86. PubMed ID: 9596763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
    Lee CK; Soike K; Hill J; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Boden J; Kleanthous H; Giannasca P; Ermak T; Weltzin R; Blanchard J; Monath TP
    Vaccine; 1999 Mar; 17(11-12):1493-505. PubMed ID: 10195786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
    Myers GA; Ermak TH; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Kleanthous H; Lee CK; Monath TP
    Vaccine; 1999 Mar; 17(11-12):1394-403. PubMed ID: 10195775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
    Michetti P; Kreiss C; Kotloff KL; Porta N; Blanco JL; Bachmann D; Herranz M; Saldinger PF; Corthésy-Theulaz I; Losonsky G; Nichols R; Simon J; Stolte M; Ackerman S; Monath TP; Blum AL
    Gastroenterology; 1999 Apr; 116(4):804-12. PubMed ID: 10092302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.
    Weltzin R; Kleanthous H; Guirakhoo F; Monath TP; Lee CK
    Vaccine; 1997 Mar; 15(4):370-6. PubMed ID: 9141207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
    Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
    Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
    Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
    J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.
    Jones FR; Hall ER; Tribble D; Savarino SJ; Cassels FJ; Porter C; Meza R; Nunez G; Espinoza N; Salazar M; Luckett R; Scott D
    Vaccine; 2006 May; 24(18):3786-92. PubMed ID: 16343702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate.
    Stadtländer CT; Gangemi JD; Khanolkar SS; Kitsos CM; Farris HE; Fulton LK; Hill JE; Huntington FK; Lee CK; Monath TP
    Dig Dis Sci; 1996 Sep; 41(9):1853-62. PubMed ID: 8794806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
    McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
    Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
    Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
    Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
    Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
    Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.